Details of the Drug

General Information of Drug (ID: DMSON1P)

Drug Name

D17.4

Synonyms

26482-53-1; 2-(1-adamantyl)ethanamine; 2-(adamantan-1-yl)ethanamine; 1-C-Ethylaminoadamantane; Tricyclo[3.3.1.13,7]decane-1-ethanamine; 1-Adamantanethylamine; 1-adamantaneethanamine; 2-Adamantan-1-yl-ethylamine; 2-adamantanylethylamine; Tricyclo(3.3.1.13,7)decane-1-ethanamine; PubChem21555; Enamine_005504; D-174; 2-(1-adamantyl)ethylamine; AC1L20RI; 2-(2-amino)ethyladamantane; Oprea1_362282; 2-(Adamant-1-yl)ethylamine; SCHEMBL973650; CHEMBL341013; Mrz-2/174; CTK1A4494; DTXSID50181075; MolPort-002-464-537

Indication

Disease Entry	ICD 11	Status	REF
Myasthenia gravis	8C6Y	Investigative	[1]
------------------------------------------------------------------------------------

Drug Type

Aptamer

Cross-matching ID

TTD ID: D03ILU

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Immunoglobulin E (IgE)	TTYJQTF	NOUNIPROTAC	Not Available	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

MIA Detail

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Therapeutic applications of aptamers. Expert Opin Investig Drugs. 2008 Jan;17(1):43-60.